Jonathan Sylvan Williams, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aldosterone | 30 | 2024 | 881 | 3.960 |
Why?
|
Sodium Chloride, Dietary | 24 | 2024 | 301 | 3.230 |
Why?
|
Hypertension | 55 | 2024 | 8617 | 2.850 |
Why?
|
Renin-Angiotensin System | 18 | 2020 | 736 | 2.490 |
Why?
|
Sodium, Dietary | 14 | 2023 | 426 | 2.250 |
Why?
|
Blood Pressure | 38 | 2024 | 8544 | 1.810 |
Why?
|
Receptors, Mineralocorticoid | 8 | 2024 | 167 | 1.700 |
Why?
|
Angiotensin II | 15 | 2020 | 844 | 1.490 |
Why?
|
Renin | 17 | 2023 | 648 | 1.260 |
Why?
|
Vitamin D | 10 | 2018 | 3311 | 0.880 |
Why?
|
Polymorphism, Single Nucleotide | 21 | 2024 | 16053 | 0.870 |
Why?
|
Histone Demethylases | 6 | 2022 | 328 | 0.850 |
Why?
|
Diet, Sodium-Restricted | 11 | 2023 | 291 | 0.840 |
Why?
|
Receptors, Calcitriol | 3 | 2012 | 361 | 0.720 |
Why?
|
Sodium Chloride | 3 | 2023 | 584 | 0.680 |
Why?
|
Hypertrophy, Left Ventricular | 3 | 2012 | 856 | 0.650 |
Why?
|
Calmodulin-Binding Proteins | 5 | 2021 | 239 | 0.600 |
Why?
|
Oxidoreductases, N-Demethylating | 3 | 2012 | 109 | 0.570 |
Why?
|
Insulin Resistance | 9 | 2016 | 3982 | 0.560 |
Why?
|
Antihypertensive Agents | 6 | 2019 | 2027 | 0.520 |
Why?
|
Hyperlipidemias | 1 | 2020 | 773 | 0.490 |
Why?
|
Resistin | 3 | 2016 | 172 | 0.480 |
Why?
|
Caveolin 1 | 4 | 2020 | 255 | 0.470 |
Why?
|
Renal Circulation | 3 | 2011 | 291 | 0.450 |
Why?
|
Calcium | 3 | 2020 | 5792 | 0.420 |
Why?
|
Second Messenger Systems | 1 | 2013 | 203 | 0.410 |
Why?
|
Sodium | 6 | 2023 | 1597 | 0.400 |
Why?
|
Zona Glomerulosa | 4 | 2022 | 87 | 0.390 |
Why?
|
Spironolactone | 3 | 2016 | 415 | 0.380 |
Why?
|
Hydroxycholecalciferols | 1 | 2011 | 44 | 0.370 |
Why?
|
Parathyroid Hormone | 2 | 2015 | 1803 | 0.370 |
Why?
|
Blood Pressure Determination | 2 | 2019 | 646 | 0.370 |
Why?
|
Cholesterol, LDL | 2 | 2020 | 2403 | 0.370 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2020 | 3253 | 0.360 |
Why?
|
Adipokines | 1 | 2012 | 309 | 0.350 |
Why?
|
Cholecalciferol | 2 | 2012 | 557 | 0.350 |
Why?
|
Calcifediol | 1 | 2011 | 160 | 0.340 |
Why?
|
Hormones | 2 | 2014 | 870 | 0.330 |
Why?
|
GTP-Binding Protein alpha Subunit, Gi2 | 2 | 2020 | 34 | 0.330 |
Why?
|
Immediate-Early Proteins | 1 | 2012 | 444 | 0.330 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2011 | 423 | 0.320 |
Why?
|
Circadian Rhythm | 4 | 2023 | 2593 | 0.320 |
Why?
|
Estrogen Receptor beta | 2 | 2021 | 171 | 0.320 |
Why?
|
Drug Resistance | 2 | 2012 | 1599 | 0.320 |
Why?
|
American Heart Association | 1 | 2014 | 1051 | 0.310 |
Why?
|
Adiponectin | 2 | 2011 | 1117 | 0.300 |
Why?
|
Electrocardiography | 3 | 2012 | 6413 | 0.300 |
Why?
|
Renal Plasma Flow | 2 | 2021 | 27 | 0.290 |
Why?
|
Lysine | 2 | 2022 | 1000 | 0.290 |
Why?
|
Diabetes Mellitus | 5 | 2019 | 5892 | 0.280 |
Why?
|
Research Personnel | 1 | 2012 | 590 | 0.280 |
Why?
|
Vitamin D Deficiency | 3 | 2012 | 1388 | 0.280 |
Why?
|
Cardiovascular Diseases | 10 | 2019 | 15661 | 0.280 |
Why?
|
Obesity | 6 | 2022 | 13091 | 0.280 |
Why?
|
Adrenal Glands | 3 | 2020 | 557 | 0.280 |
Why?
|
Kidney Diseases | 2 | 2023 | 2100 | 0.280 |
Why?
|
Cholesterol | 3 | 2020 | 2913 | 0.280 |
Why?
|
Angiotensinogen | 2 | 2021 | 161 | 0.270 |
Why?
|
Nerve Tissue Proteins | 5 | 2021 | 4413 | 0.270 |
Why?
|
Nucleotides | 3 | 2024 | 455 | 0.270 |
Why?
|
Male | 72 | 2024 | 365203 | 0.270 |
Why?
|
Sex Factors | 7 | 2024 | 10633 | 0.260 |
Why?
|
Middle Aged | 53 | 2024 | 223737 | 0.260 |
Why?
|
Cardiovascular System | 1 | 2013 | 841 | 0.250 |
Why?
|
Merkel Cells | 2 | 2016 | 24 | 0.250 |
Why?
|
Female | 68 | 2024 | 397515 | 0.250 |
Why?
|
Epigenesis, Genetic | 3 | 2022 | 3836 | 0.250 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 1514 | 0.250 |
Why?
|
Body Mass Index | 7 | 2015 | 13055 | 0.240 |
Why?
|
Humans | 88 | 2024 | 768970 | 0.240 |
Why?
|
Polymorphism, Genetic | 5 | 2017 | 4251 | 0.230 |
Why?
|
Hyperaldosteronism | 2 | 2013 | 252 | 0.220 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2024 | 153 | 0.220 |
Why?
|
Cell Membrane | 1 | 2013 | 3659 | 0.220 |
Why?
|
Vitamins | 1 | 2012 | 1638 | 0.220 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 3518 | 0.220 |
Why?
|
Adult | 44 | 2024 | 223851 | 0.210 |
Why?
|
Cardiology | 1 | 2014 | 1701 | 0.200 |
Why?
|
Dyspepsia | 1 | 2023 | 116 | 0.200 |
Why?
|
Membrane Proteins | 5 | 2021 | 7885 | 0.200 |
Why?
|
Captopril | 2 | 2013 | 262 | 0.200 |
Why?
|
Spouses | 1 | 2005 | 286 | 0.200 |
Why?
|
Patient-Centered Care | 1 | 2012 | 1447 | 0.190 |
Why?
|
Estrogens | 2 | 2022 | 1536 | 0.190 |
Why?
|
Myocardial Contraction | 1 | 2006 | 1526 | 0.180 |
Why?
|
Genotype | 14 | 2024 | 13048 | 0.180 |
Why?
|
Gene Frequency | 6 | 2016 | 3626 | 0.180 |
Why?
|
Bereavement | 1 | 2005 | 310 | 0.180 |
Why?
|
Age Factors | 6 | 2024 | 18435 | 0.170 |
Why?
|
Natriuresis | 1 | 2020 | 106 | 0.170 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7460 | 0.170 |
Why?
|
Linkage Disequilibrium | 4 | 2012 | 2000 | 0.170 |
Why?
|
Paraventricular Hypothalamic Nucleus | 1 | 2020 | 121 | 0.170 |
Why?
|
Aged | 23 | 2024 | 171786 | 0.160 |
Why?
|
Aminopeptidases | 1 | 2019 | 114 | 0.160 |
Why?
|
Animals | 29 | 2023 | 169335 | 0.160 |
Why?
|
Sleep | 4 | 2023 | 4820 | 0.150 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2019 | 304 | 0.150 |
Why?
|
Linear Models | 4 | 2012 | 5891 | 0.150 |
Why?
|
Insulin | 7 | 2022 | 6610 | 0.150 |
Why?
|
Homeostasis | 6 | 2016 | 3347 | 0.150 |
Why?
|
Hypertension, Renal | 2 | 2021 | 135 | 0.150 |
Why?
|
Thyrotropin | 1 | 2021 | 834 | 0.150 |
Why?
|
Mice, Knockout | 8 | 2022 | 14484 | 0.140 |
Why?
|
Alleles | 8 | 2021 | 6901 | 0.140 |
Why?
|
Receptors, Adrenergic, beta-2 | 2 | 2010 | 216 | 0.140 |
Why?
|
Ectodysplasins | 1 | 2016 | 12 | 0.140 |
Why?
|
Hypothyroidism | 1 | 2021 | 667 | 0.130 |
Why?
|
Wnt1 Protein | 1 | 2016 | 123 | 0.130 |
Why?
|
Endothelin-1 | 1 | 2017 | 296 | 0.130 |
Why?
|
Calcitriol | 1 | 2018 | 303 | 0.130 |
Why?
|
Triglycerides | 3 | 2020 | 2464 | 0.130 |
Why?
|
Kidney Calculi | 1 | 2020 | 469 | 0.130 |
Why?
|
Mice | 17 | 2023 | 82072 | 0.130 |
Why?
|
Fasting | 2 | 2020 | 1610 | 0.130 |
Why?
|
Touch | 2 | 2016 | 316 | 0.130 |
Why?
|
Kidney | 4 | 2023 | 7058 | 0.120 |
Why?
|
Sleep Deprivation | 1 | 2022 | 848 | 0.120 |
Why?
|
Dyslipidemias | 2 | 2020 | 873 | 0.120 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 13698 | 0.120 |
Why?
|
Signal Transduction | 10 | 2020 | 23653 | 0.120 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3438 | 0.120 |
Why?
|
Potassium | 4 | 2020 | 1315 | 0.120 |
Why?
|
Thyroid Gland | 1 | 2021 | 1171 | 0.120 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2021 | 2297 | 0.120 |
Why?
|
Cohort Studies | 11 | 2024 | 41808 | 0.120 |
Why?
|
Cross-Sectional Studies | 8 | 2021 | 26395 | 0.110 |
Why?
|
Diabetic Ketoacidosis | 1 | 2017 | 257 | 0.110 |
Why?
|
Water-Electrolyte Balance | 1 | 2015 | 326 | 0.110 |
Why?
|
Infusions, Intravenous | 3 | 2015 | 2231 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 8 | 2021 | 18068 | 0.110 |
Why?
|
Sodium-Bicarbonate Symporters | 1 | 2012 | 30 | 0.100 |
Why?
|
Iodide Peroxidase | 2 | 2021 | 295 | 0.100 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1106 | 0.100 |
Why?
|
Mineralocorticoids | 1 | 2012 | 37 | 0.100 |
Why?
|
Risk Factors | 13 | 2020 | 74976 | 0.100 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39394 | 0.100 |
Why?
|
Young Adult | 11 | 2021 | 60131 | 0.100 |
Why?
|
Lipid Metabolism | 2 | 2020 | 1904 | 0.100 |
Why?
|
Norepinephrine | 2 | 2011 | 899 | 0.100 |
Why?
|
Phenotype | 8 | 2014 | 16731 | 0.100 |
Why?
|
Hedgehog Proteins | 1 | 2016 | 771 | 0.100 |
Why?
|
Hemodynamics | 4 | 2021 | 4199 | 0.090 |
Why?
|
Wakefulness | 1 | 2018 | 1284 | 0.090 |
Why?
|
Genetic Association Studies | 4 | 2017 | 2748 | 0.090 |
Why?
|
Rats, Wistar | 4 | 2018 | 1890 | 0.090 |
Why?
|
Multivariate Analysis | 4 | 2012 | 12095 | 0.090 |
Why?
|
Health Plan Implementation | 1 | 2014 | 338 | 0.090 |
Why?
|
Haplotypes | 3 | 2012 | 2725 | 0.090 |
Why?
|
Infusions, Parenteral | 1 | 2010 | 396 | 0.090 |
Why?
|
Nutrigenomics | 1 | 2010 | 23 | 0.090 |
Why?
|
Cyclic GMP | 1 | 2011 | 394 | 0.090 |
Why?
|
Blood Glucose | 5 | 2019 | 6435 | 0.080 |
Why?
|
Cross-Over Studies | 2 | 2006 | 2108 | 0.080 |
Why?
|
Adipose Tissue | 3 | 2016 | 3335 | 0.080 |
Why?
|
France | 1 | 2010 | 497 | 0.080 |
Why?
|
Sphygmomanometers | 1 | 2009 | 20 | 0.080 |
Why?
|
Prognosis | 5 | 2020 | 30046 | 0.080 |
Why?
|
Glucose | 2 | 2022 | 4352 | 0.080 |
Why?
|
Stethoscopes | 1 | 2009 | 30 | 0.080 |
Why?
|
Vasoconstriction | 1 | 2011 | 593 | 0.080 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2012 | 794 | 0.080 |
Why?
|
Drug Synergism | 1 | 2012 | 1762 | 0.070 |
Why?
|
Research Support as Topic | 1 | 2012 | 696 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2018 | 2905 | 0.070 |
Why?
|
PPAR gamma | 1 | 2010 | 487 | 0.070 |
Why?
|
Prospective Studies | 4 | 2023 | 54962 | 0.070 |
Why?
|
Albuminuria | 2 | 2023 | 658 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 10400 | 0.070 |
Why?
|
Adolescent | 9 | 2021 | 89244 | 0.070 |
Why?
|
Logistic Models | 3 | 2012 | 13318 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2020 | 12467 | 0.060 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2015 | 1751 | 0.060 |
Why?
|
Cerebrovascular Circulation | 1 | 2016 | 2734 | 0.060 |
Why?
|
Diet | 4 | 2018 | 8088 | 0.060 |
Why?
|
Environment | 1 | 2011 | 1122 | 0.060 |
Why?
|
Europe | 1 | 2012 | 3441 | 0.060 |
Why?
|
Models, Animal | 1 | 2011 | 2122 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2016 | 3612 | 0.060 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2011 | 1493 | 0.060 |
Why?
|
Depression | 1 | 2005 | 8231 | 0.060 |
Why?
|
Hypokalemia | 1 | 2006 | 152 | 0.060 |
Why?
|
United States | 5 | 2014 | 73186 | 0.060 |
Why?
|
Diastole | 1 | 2006 | 785 | 0.060 |
Why?
|
Risk Assessment | 3 | 2019 | 24333 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2015 | 1300 | 0.060 |
Why?
|
History, 16th Century | 1 | 2003 | 70 | 0.050 |
Why?
|
Hydrocortisone | 2 | 2012 | 1841 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2016 | 12806 | 0.050 |
Why?
|
Weight Loss | 1 | 2015 | 2721 | 0.050 |
Why?
|
Mice, Inbred C57BL | 5 | 2023 | 22379 | 0.050 |
Why?
|
Thiazolidinediones | 1 | 2006 | 461 | 0.050 |
Why?
|
Menstrual Cycle | 1 | 2006 | 546 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2012 | 2167 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2011 | 2149 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2015 | 5151 | 0.050 |
Why?
|
Calcium Channels, L-Type | 1 | 2023 | 244 | 0.050 |
Why?
|
Progesterone | 1 | 2006 | 752 | 0.050 |
Why?
|
Vasodilation | 1 | 2006 | 967 | 0.050 |
Why?
|
Time | 1 | 2023 | 552 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2011 | 3232 | 0.050 |
Why?
|
Societies, Medical | 1 | 2014 | 3968 | 0.050 |
Why?
|
Immunotherapy | 1 | 2017 | 4756 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2018 | 12253 | 0.050 |
Why?
|
Amlodipine | 1 | 2021 | 84 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15471 | 0.040 |
Why?
|
History, 19th Century | 1 | 2003 | 715 | 0.040 |
Why?
|
Thyroid Function Tests | 1 | 2021 | 289 | 0.040 |
Why?
|
Posture | 1 | 2005 | 957 | 0.040 |
Why?
|
Hypoglycemic Agents | 2 | 2019 | 3110 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2013 | 10765 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 8055 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 5801 | 0.040 |
Why?
|
Spirituality | 1 | 2005 | 430 | 0.040 |
Why?
|
Rats | 4 | 2020 | 23786 | 0.040 |
Why?
|
Vasoconstrictor Agents | 2 | 2013 | 657 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5434 | 0.040 |
Why?
|
Genetic Variation | 2 | 2011 | 6611 | 0.040 |
Why?
|
Italy | 1 | 2020 | 856 | 0.040 |
Why?
|
Calcium, Dietary | 1 | 2020 | 533 | 0.040 |
Why?
|
Disease Progression | 1 | 2014 | 13674 | 0.040 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2021 | 702 | 0.030 |
Why?
|
Endocrinology | 1 | 2003 | 443 | 0.030 |
Why?
|
Sirolimus | 1 | 2024 | 1540 | 0.030 |
Why?
|
Aldehyde Reductase | 1 | 2016 | 70 | 0.030 |
Why?
|
Eating | 1 | 2023 | 1542 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11932 | 0.030 |
Why?
|
Glutamate Decarboxylase | 1 | 2017 | 239 | 0.030 |
Why?
|
Minerals | 1 | 2018 | 282 | 0.030 |
Why?
|
Time Factors | 2 | 2022 | 40261 | 0.030 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.030 |
Why?
|
Molecular Epidemiology | 1 | 2018 | 473 | 0.030 |
Why?
|
Blotting, Western | 2 | 2014 | 5033 | 0.030 |
Why?
|
Polysomnography | 1 | 2022 | 1871 | 0.030 |
Why?
|
History, 20th Century | 1 | 2003 | 2771 | 0.030 |
Why?
|
Disease Models, Animal | 4 | 2018 | 18354 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2024 | 2063 | 0.030 |
Why?
|
Social Support | 1 | 2005 | 2193 | 0.030 |
Why?
|
Vasodilator Agents | 2 | 2011 | 990 | 0.030 |
Why?
|
Hair Follicle | 1 | 2016 | 219 | 0.030 |
Why?
|
Rest | 1 | 2018 | 951 | 0.030 |
Why?
|
Hypertriglyceridemia | 1 | 2016 | 293 | 0.030 |
Why?
|
Aging | 1 | 2012 | 8745 | 0.030 |
Why?
|
Genetic Markers | 2 | 2011 | 2604 | 0.030 |
Why?
|
Neurosecretory Systems | 1 | 2014 | 223 | 0.030 |
Why?
|
Inflammation | 1 | 2012 | 10868 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2016 | 59739 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2017 | 13594 | 0.030 |
Why?
|
Morphogenesis | 1 | 2016 | 747 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5323 | 0.020 |
Why?
|
Potassium, Dietary | 1 | 2012 | 103 | 0.020 |
Why?
|
Blood Vessels | 1 | 2018 | 1110 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 682 | 0.020 |
Why?
|
Prevalence | 1 | 2009 | 15879 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2014 | 874 | 0.020 |
Why?
|
Skin | 2 | 2016 | 4506 | 0.020 |
Why?
|
Parathyroid Glands | 1 | 2013 | 522 | 0.020 |
Why?
|
Epidermis | 1 | 2014 | 539 | 0.020 |
Why?
|
Remission Induction | 1 | 2017 | 2408 | 0.020 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2011 | 262 | 0.020 |
Why?
|
Echocardiography, Doppler | 1 | 2015 | 898 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2024 | 4939 | 0.020 |
Why?
|
Organ Size | 1 | 2016 | 2268 | 0.020 |
Why?
|
Metabolome | 1 | 2018 | 1009 | 0.020 |
Why?
|
Guanylate Cyclase | 1 | 2011 | 206 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2014 | 2560 | 0.020 |
Why?
|
p-Aminohippuric Acid | 1 | 2010 | 36 | 0.020 |
Why?
|
Diuretics | 1 | 2013 | 614 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 2016 | 873 | 0.020 |
Why?
|
Goals | 1 | 2015 | 717 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 81903 | 0.020 |
Why?
|
Mass Screening | 1 | 2006 | 5457 | 0.020 |
Why?
|
Keratinocytes | 1 | 2014 | 876 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4592 | 0.020 |
Why?
|
Ligands | 1 | 2016 | 3283 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 19023 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2016 | 2635 | 0.020 |
Why?
|
Immune System | 1 | 2014 | 800 | 0.020 |
Why?
|
Neural Pathways | 1 | 2020 | 3120 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2020 | 8144 | 0.020 |
Why?
|
Gene Deletion | 1 | 2016 | 2674 | 0.020 |
Why?
|
Autoantibodies | 1 | 2017 | 2120 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2011 | 706 | 0.020 |
Why?
|
Postoperative Care | 1 | 2015 | 1481 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 22296 | 0.020 |
Why?
|
Quantitative Trait, Heritable | 1 | 2011 | 540 | 0.020 |
Why?
|
Neurogenesis | 1 | 2014 | 865 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3813 | 0.020 |
Why?
|
Genetics, Medical | 1 | 2010 | 334 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2012 | 1364 | 0.020 |
Why?
|
Mutation | 3 | 2020 | 30266 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6320 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2576 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2016 | 2228 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1798 | 0.020 |
Why?
|
DNA Repair | 1 | 2016 | 2054 | 0.020 |
Why?
|
Administration, Sublingual | 1 | 2006 | 60 | 0.020 |
Why?
|
Exons | 1 | 2012 | 2395 | 0.020 |
Why?
|
Gastric Bypass | 1 | 2015 | 824 | 0.020 |
Why?
|
Edema | 1 | 2010 | 766 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2014 | 2149 | 0.020 |
Why?
|
Cognition | 1 | 2023 | 7081 | 0.020 |
Why?
|
Preoperative Care | 1 | 2015 | 2258 | 0.020 |
Why?
|
Glucose Clamp Technique | 1 | 2006 | 263 | 0.020 |
Why?
|
Medication Adherence | 1 | 2017 | 2192 | 0.020 |
Why?
|
Neoplasms | 1 | 2014 | 22389 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6086 | 0.020 |
Why?
|
Nitroglycerin | 1 | 2006 | 332 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2011 | 1112 | 0.010 |
Why?
|
Cause of Death | 1 | 2015 | 3721 | 0.010 |
Why?
|
Hyperemia | 1 | 2006 | 224 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3492 | 0.010 |
Why?
|
Brachial Artery | 1 | 2006 | 373 | 0.010 |
Why?
|
Health Status | 1 | 2017 | 4095 | 0.010 |
Why?
|
Aorta | 1 | 2011 | 2046 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14794 | 0.010 |
Why?
|
Reference Values | 1 | 2010 | 4940 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2011 | 6236 | 0.010 |
Why?
|
Heart Failure | 1 | 2006 | 11879 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13510 | 0.010 |
Why?
|
Skin Diseases | 1 | 2010 | 1085 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9344 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21547 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2011 | 3726 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2006 | 2932 | 0.010 |
Why?
|
Liver | 1 | 2016 | 7578 | 0.010 |
Why?
|
Regression Analysis | 1 | 2010 | 6346 | 0.010 |
Why?
|
Odds Ratio | 1 | 2012 | 9684 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 2006 | 1820 | 0.010 |
Why?
|
India | 1 | 2006 | 2334 | 0.010 |
Why?
|
Estradiol | 1 | 2006 | 1952 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2011 | 3592 | 0.010 |
Why?
|
Myocardium | 1 | 2011 | 4790 | 0.010 |
Why?
|
DNA | 1 | 2012 | 7214 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2006 | 4862 | 0.010 |
Why?
|
Models, Biological | 1 | 2014 | 9499 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4265 | 0.010 |
Why?
|
Neurons | 1 | 2016 | 9519 | 0.010 |
Why?
|
Lipids | 1 | 2006 | 3345 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2006 | 4428 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12801 | 0.010 |
Why?
|
Child | 1 | 2007 | 80960 | 0.000 |
Why?
|